WA Life Sciences Innovation Hub

It’s time for the December edition of our MedTech Startup Spotlight series! This month, we're highlighting a startup that has chosen to relocate all the way from Australia (!) to set up shop here in #RhodeIsland for its next phase of growth. Meet VeinTech, a MedTech company impacting the most common invasive medical procedure on the planet with a patented ultrasound-based technology to address the high failure rates of IV insertions. To read on and learn how VeinTech's world-first innovation is enabling the visualization of vein pathways, check out the NEMIC blog: https://lnkd.in/ez6arBgn #VeinTech Perth Biodesign Government of Western Australia Stephen Dawson Kevin Pfleger Peter Traianou Natasha M. #Perth Mayor Brett Smiley City of Providence RI Life Science Hub #MedTech #HealthTech #Healthcare #Innovation Nikhilesh Bappoo Nicholas Buckley

We are proud to announce that eight Australian startups developing innovations with the potential to save lives and improve wellbeing will receive grants totalling $18.5 million thanks to the first CUREator+ funding round 🎉 Delivered in partnership with Brandon BioCatalyst (Brandon Capital) and ANDHealth, CUREator+ is a national program focused on accelerating the research translation and commercialisation of preclinical and clinical early-stage Australian medical research and medical innovations with commercial potential. These innovations include drugs (novel and repurposed), devices, diagnostics and digital technologies that address unmet needs. The first-round recipients are: ⭐️ Amplificare: Enabling rapid assessment of the efficacy of cancer treatments ⭐️ Baymatob: AI-powered platform providing early warning for treatable pregnancy and labour complications ⭐️ Currus Biologics Pty Ltd: Technology to develop CAR T-cell Therapy in tumours ⭐️ Kinoxis Therapeutics Pty Ltd: An alternative to antipsychotics for managing agitation and aggression in dementia ⭐️ Micromune Therapeutics: A therapy for treating inflammatory bowel disease ⭐️ Mirugen: Utilising gene therapy to restore vision in patients with ‘incurable’ blindness ⭐️ OncoRes Medical: Imaging technology which differentiates cancer from healthy tissue ⭐️ SeeTreat Medical: Software to improve the accuracy and effectiveness of radiation therapy for breast cancer The Hon Mark Butler MP, Minister for Health and Aged Care, said, “Turning new research into medicines and tools which can be used to treat patients is often a long and costly process. Our support will ensure innovative research can become life changing and lifesaving treatments.” ANDHealth CEO Bronwyn Le Grice said, “In the current market, substantive equity-free funding such as provided under CUREator+ and access to global industry leaders with proven track records, can make a material difference to the speed and success of commercialising these exciting new technologies.” 👉 Learn more: https://loom.ly/pUOUliw CUREator+ is supported by funding from the Medical Research Future Fund (MRFF) BioMedTech Incubator (BMTI) program.

📢 𝗢𝘂𝗿 𝟮𝟬𝟮𝟰 𝗔𝗻𝗻𝘂𝗮𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗶𝘀 𝗼𝘂𝘁 𝗻𝗼𝘄! We have continued our work across FY2024 supporting Australia’s life science innovators to meet the commercialisation challenges of developing new medical devices and therapeutics. By providing funding through our accelerator programs, building sector capabilities and cementing collaborations between industry and research, we are helping to bring life-saving medical products from bench to bedside. Across all programs, MTPConnect’s $152 million in strategic funding investments committed to supporting 199 projects has: ✔️yielded $𝟭.𝟯 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 in additional industry contributions and flow-on external investment ✔️seen 𝟭,𝟲𝟵𝟲 new technologies invented or progressed ✔️created 𝟮,𝟰𝟰𝟳 new jobs ✔️launched 𝟯𝟳 new products And the overall economic impact of MTPConnect’s activities shows a total attributable return of ~$𝟳.𝟱 𝗯𝗶𝗹𝗹𝗶𝗼𝗻. 𝗙𝗶𝗻𝗱 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺 𝗮𝗻𝗱 𝘁𝗵𝗲 𝘄𝗼𝗿𝗸 𝘄𝗲 𝗱𝗼 𝘁𝗼 𝗯𝗮𝗰𝗸 𝘀𝘁𝗮𝗿𝘁-𝘂𝗽𝘀, 𝗲𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝘀 𝗮𝗻𝗱 𝗦𝗠𝗘𝘀 𝘁𝗼 𝗴𝗿𝗼𝘄, 𝘀𝗰𝗮𝗹𝗲 𝗮𝗻𝗱 𝗽𝗿𝗼𝘀𝗽𝗲𝗿. https://lnkd.in/gdSB-XKM Stuart Dignam, Hon. Jaala Pulford, Ed Husic MP, Tracey Wilkinson, Dana Bell, Andrew Bowskill, Duncan Macinnis, Amelia Vom, Lisa Dubé, Danielle Shand, Lauren Eve Kelly, Elizabeth Stares, Department of Industry, Science and Resources

Diversify WA 2024 is a progress report on the State's economic development framework. It highlights Western Australia's economic strengths and the work being done to ensure we have the rights jobs for tomorrow. Key highlights since the last report in 2021 are: 📈 Record non-mining investment of $36 billion in 2023-24 📈 6.8% growth growth in WA's gross state product across the 3 years to 2023-24 📈 An increase of 15% of employment in the defence industries sector in 2022-23 📈 14% growth of direct full-time equivalent employment in the battery and critical minerals industry between 2022-23 and 2023-24 🔋 Western Australia produces approximately half the world's supply of lithium and despite recent prices drops the fundamentals for the sector are strong 👍Western Australia is the only jurisdiction to hold a triple-A credit rating Looking forward the report also outlines: 🏦Continued Government investment into cross-sector enablers to support growth and development across industries ⚒️Planning for major infrastructure to support new economic opportunities, including Western Trade Coast. Read or download the report from our website 👉 https://loom.ly/cHqHkVE

Our first Software as a Medical Device (SaMD) webinar of 2025 is already almost sold out 🔥 Come along to hear an overview of the updated SaMD regulations and have your questions answered by the Therapeutic Goods Administration. Act swiftly, only two spots remain: https://loom.ly/5QOPWgU ✳️ An Overview: SaMD Regulation by the TGA Date: Wednesday 22 January 2025 Time: 10:30 am – 11:30 am (AEDT) Location: Virtual via Zoom